{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T13:44:36Z","timestamp":1767015876244,"version":"3.48.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Orthop Surg Traumatol"],"DOI":"10.1007\/s00590-025-04399-x","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:22:54Z","timestamp":1750638174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical observations on arthroscopic removal of urate deposits in the knee: a seven-case series"],"prefix":"10.1007","volume":"35","author":[{"given":"Wanping","family":"Lv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianchun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"4399_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cger.2016.08.010","volume":"33","author":"H El-Zawawy","year":"2017","unstructured":"El-Zawawy H, Mandell BF (2017) Update on crystal-induced arthritides. Clin Geriatr Med 33:135\u2013144. https:\/\/doi.org\/10.1016\/j.cger.2016.08.010","journal-title":"Clin Geriatr Med"},{"key":"4399_CR2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.rdc.2022.03.001","volume":"48","author":"SF Keller","year":"2022","unstructured":"Keller SF, Mandell BF (2022) Management and cure of gouty arthritis. Rheum Dis Clin North Am 48:479\u2013492. https:\/\/doi.org\/10.1016\/j.rdc.2022.03.001","journal-title":"Rheum Dis Clin North Am"},{"key":"4399_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.mcna.2020.09.013","volume":"105","author":"SF Keller","year":"2021","unstructured":"Keller SF, Mandell BF (2021) Management and cure of gouty arthritis. Med Clin North Am 105:297\u2013310. https:\/\/doi.org\/10.1016\/j.mcna.2020.09.013","journal-title":"Med Clin North Am"},{"key":"4399_CR4","first-page":"264","volume":"43","author":"D Bhadu","year":"2018","unstructured":"Bhadu D, Das SK, Wakhlu A et al (2018) Articular cartilage of knee and first MTP joint are the preferred sites to find double contour sign as an evidence of urate crystal deposition in asymptomatic hyperuricemic individuals. Acta Reumatol Port 43:264\u2013268","journal-title":"Acta Reumatol Port"},{"key":"4399_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/art.1780150209","volume":"15","author":"JN Loeb","year":"1972","unstructured":"Loeb JN (1972) The influence of temperature on the solubility of monosodium urate. Arthritis Rheum 15:189\u2013192. https:\/\/doi.org\/10.1002\/art.1780150209","journal-title":"Arthritis Rheum"},{"key":"4399_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3390\/jcm11010166","volume":"11","author":"JS Weaver","year":"2021","unstructured":"Weaver JS, Vina ER, Munk PL et al (2021) Gouty arthropathy: review of clinical manifestations and treatment, with emphasis on imaging. J Clin Med 11:166. https:\/\/doi.org\/10.3390\/jcm11010166","journal-title":"J Clin Med"},{"key":"4399_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4081\/reumatismo.2011.238","volume":"63","author":"W Grassi","year":"2012","unstructured":"Grassi W, De Angelis R (2012) Clinical features of gout. Reumatismo 63:238\u2013245. https:\/\/doi.org\/10.4081\/reumatismo.2011.238","journal-title":"Reumatismo"},{"key":"4399_CR8","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","volume":"16","author":"M Dehlin","year":"2020","unstructured":"Dehlin M, Jacobsson L, Roddy E (2020) Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol 16:380\u2013390. https:\/\/doi.org\/10.1038\/s41584-020-0441-1","journal-title":"Nat Rev Rheumatol"},{"key":"4399_CR9","doi-asserted-by":"publisher","first-page":"10853","DOI":"10.3390\/ijms251910853","volume":"25","author":"T-K Yao","year":"2024","unstructured":"Yao T-K, Lee R-P, Wu W-T et al (2024) Advances in gouty arthritis management: integration of established therapies, emerging treatments, and lifestyle interventions. Int J Mol Sci 25:10853. https:\/\/doi.org\/10.3390\/ijms251910853","journal-title":"Int J Mol Sci"},{"key":"4399_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/14740338.2019.1594771","volume":"18","author":"L Strilchuk","year":"2019","unstructured":"Strilchuk L, Fogacci F, Cicero AF (2019) Safety and tolerability of available urate-lowering drugs: a critical review. Expert Opin Drug Saf 18:261\u2013271. https:\/\/doi.org\/10.1080\/14740338.2019.1594771","journal-title":"Expert Opin Drug Saf"},{"key":"4399_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.actbio.2024.08.032","volume":"187","author":"H Yi","year":"2024","unstructured":"Yi H, Yu H, Wang L et al (2024) Microneedle transdermal drug delivery as a candidate for the treatment of gouty arthritis: Material structure, design strategies and prospects. Acta Biomater 187:20\u201350. https:\/\/doi.org\/10.1016\/j.actbio.2024.08.032","journal-title":"Acta Biomater"},{"key":"4399_CR12","doi-asserted-by":"publisher","first-page":"1295154","DOI":"10.3389\/fimmu.2023.1295154","volume":"14","author":"Z Ni","year":"2023","unstructured":"Ni Z, Xiao Q, Xia Z et al (2023) Electroacupuncture for acute gouty arthritis: a systematic review and meta-analysis of randomized controlled trials. Front Immunol 14:1295154. https:\/\/doi.org\/10.3389\/fimmu.2023.1295154","journal-title":"Front Immunol"},{"key":"4399_CR13","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1097\/RHU.0000000000001608","volume":"28","author":"B Tang","year":"2022","unstructured":"Tang B, Zeng X, Fan C (2022) Significantly better efficacy for acute ankle gouty arthritis through arthroscopic debridement compared with simple drug therapy: a longitudinal study with 1-year follow-up. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis 28:e69\u2013e72. https:\/\/doi.org\/10.1097\/RHU.0000000000001608","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"4399_CR14","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.5312\/wjo.v15.i11.1101","volume":"15","author":"GA Utoyo","year":"2024","unstructured":"Utoyo GA, Calvin C (2024) Arthroscopic synovectomy for synovial hyperplasia in chronic knee gouty arthritis: a case report. World J Orthop 15:1101\u20131108. https:\/\/doi.org\/10.5312\/wjo.v15.i11.1101","journal-title":"World J Orthop"},{"key":"4399_CR15","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","volume":"74","author":"T Neogi","year":"2015","unstructured":"Neogi T, Jansen TLTA, Dalbeth N et al (2015) 2015 Gout classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 74:1789\u20131798. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208237","journal-title":"Ann Rheum Dis"},{"key":"4399_CR16","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"N Dalbeth","year":"2021","unstructured":"Dalbeth N, Gosling AL, Gaffo A et al (2021) Gout. Lancet Lond Engl 397:1843\u20131855. https:\/\/doi.org\/10.1016\/S0140-6736(21)00569-9","journal-title":"Lancet Lond Engl"},{"key":"4399_CR17","doi-asserted-by":"publisher","unstructured":"GBD 2021 Gout Collaborators. Global, regional, and national burden of gout, 1990\u20132020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol 2024; 6: e507\u2013e517. https:\/\/doi.org\/10.1016\/S2665-9913(24)00117-6","DOI":"10.1016\/S2665-9913(24)00117-6"},{"key":"4399_CR18","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.3390\/jcm10091880","volume":"10","author":"P Galozzi","year":"2021","unstructured":"Galozzi P, Bindoli S, Doria A et al (2021) Autoinflammatory Features in Gouty Arthritis. J Clin Med 10:1880. https:\/\/doi.org\/10.3390\/jcm10091880","journal-title":"J Clin Med"},{"key":"4399_CR19","doi-asserted-by":"publisher","first-page":"12189","DOI":"10.7150\/thno.48028","volume":"10","author":"C Yin","year":"2020","unstructured":"Yin C, Liu B, Li Y et al (2020) IL-33\/ST2 induces neutrophil-dependent reactive oxygen species production and mediates gout pain. Theranostics 10:12189\u201312203. https:\/\/doi.org\/10.7150\/thno.48028","journal-title":"Theranostics"},{"key":"4399_CR20","doi-asserted-by":"publisher","first-page":"188","DOI":"10.7150\/ijms.88447","volume":"21","author":"M Ling","year":"2024","unstructured":"Ling M, Gan J, Hu M et al (2024) IL1A regulates the inflammation in gout through the Toll-like receptors pathway. Int J Med Sci 21:188\u2013199. https:\/\/doi.org\/10.7150\/ijms.88447","journal-title":"Int J Med Sci"},{"key":"4399_CR21","doi-asserted-by":"publisher","first-page":"4380","DOI":"10.21037\/qims-22-1208","volume":"13","author":"X-Y Zhang","year":"2023","unstructured":"Zhang X-Y, Tang C-X, Zhou F et al (2023) Burden and distribution of monosodium urate deposition in patients with hyperuricemia and gout: a cross-sectional Chinese population-based dual-energy CT study. Quant Imaging Med Surg 13:4380\u20134391. https:\/\/doi.org\/10.21037\/qims-22-1208","journal-title":"Quant Imaging Med Surg"},{"key":"4399_CR22","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3899\/jrheum.090034","volume":"36","author":"SY Kim","year":"2009","unstructured":"Kim SY, Choi HK (2009) Gout and quality of life. J Rheumatol 36:865\u2013868. https:\/\/doi.org\/10.3899\/jrheum.090034","journal-title":"J Rheumatol"},{"key":"4399_CR23","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1080\/03009742.2022.2157962","volume":"52","author":"AJ Landgren","year":"2023","unstructured":"Landgren AJ, Klingberg E, Jacobsson L et al (2023) Health-related quality of life in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis, results from a cross-sectional survey in Western Sweden. Scand J Rheumatol 52:506\u2013518. https:\/\/doi.org\/10.1080\/03009742.2022.2157962","journal-title":"Scand J Rheumatol"},{"key":"4399_CR24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1055\/s-0044-1785471","volume":"28","author":"I Sudo\u0142-Szopi\u0144ska","year":"2024","unstructured":"Sudo\u0142-Szopi\u0144ska I, Lanckoro\u0144ski M, Teh J et al (2024) Advanced imaging of gout and other inflammatory diseases around the knee. Semin Musculoskelet Radiol 28:337\u2013351. https:\/\/doi.org\/10.1055\/s-0044-1785471","journal-title":"Semin Musculoskelet Radiol"},{"key":"4399_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1794","volume":"357","author":"SK Rai","year":"2017","unstructured":"Rai SK, Fung TT, Lu N et al (2017) The dietary approaches to stop hypertension (DASH) diet, Western diet, and risk of gout in men: prospective cohort study. BMJ 357:j1794. https:\/\/doi.org\/10.1136\/bmj.j1794","journal-title":"BMJ"},{"key":"4399_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11926-021-01020-y","volume":"23","author":"C Yokose","year":"2021","unstructured":"Yokose C, McCormick N, Choi HK (2021) Dietary and lifestyle-centered approach in gout care and prevention. Curr Rheumatol Rep 23:51. https:\/\/doi.org\/10.1007\/s11926-021-01020-y","journal-title":"Curr Rheumatol Rep"},{"key":"4399_CR27","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1053\/j.ackd.2012.07.011","volume":"19","author":"E Kedar","year":"2012","unstructured":"Kedar E, Simkin PA (2012) A perspective on diet and gout. Adv Chronic Kidney Dis 19:392\u2013397. https:\/\/doi.org\/10.1053\/j.ackd.2012.07.011","journal-title":"Adv Chronic Kidney Dis"},{"key":"4399_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2021.101723","volume":"35","author":"A Danve","year":"2021","unstructured":"Danve A, Sehra ST, Neogi T (2021) Role of diet in hyperuricemia and gout. Best Pract Res Clin Rheumatol 35:101723. https:\/\/doi.org\/10.1016\/j.berh.2021.101723","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"4399_CR29","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/acr.24180","volume":"72","author":"JD FitzGerald","year":"2020","unstructured":"FitzGerald JD, Dalbeth N, Mikuls T et al (2020) 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res 72:744\u2013760. https:\/\/doi.org\/10.1002\/acr.24180","journal-title":"Arthritis Care Res"},{"key":"4399_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette P, Doherty M, Pascual E et al (2017) 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 76:29\u201342. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209707","journal-title":"Ann Rheum Dis"},{"key":"4399_CR31","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46649","volume":"15","author":"MJ Quintana","year":"2023","unstructured":"Quintana MJ, Shum AZ, Folse MS et al (2023) Gout treatment and clinical considerations: the role of pegloticase, colchicine, and febuxostat. Cureus 15:e46649. https:\/\/doi.org\/10.7759\/cureus.46649","journal-title":"Cureus"},{"key":"4399_CR32","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2174\/1381612824666180123110042","volume":"24","author":"C Angelidis","year":"2018","unstructured":"Angelidis C, Kotsialou Z, Kossyvakis C et al (2018) Colchicine pharmacokinetics and mechanism of action. Curr Pharm Des 24:659\u2013663. https:\/\/doi.org\/10.2174\/1381612824666180123110042","journal-title":"Curr Pharm Des"},{"key":"4399_CR33","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s10787-021-00865-0","volume":"29","author":"A Gholoobi","year":"2021","unstructured":"Gholoobi A, Askari VR, Naghedinia H et al (2021) Colchicine effectively attenuates inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) in patients with non-ST-segment elevation myocardial infarction: a randomised, double-blind, placebo-controlled clinical trial. Inflammopharmacology 29:1379\u20131387. https:\/\/doi.org\/10.1007\/s10787-021-00865-0","journal-title":"Inflammopharmacology"},{"key":"4399_CR34","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1136\/heartjnl-2023-323177","volume":"110","author":"B Tucker","year":"2024","unstructured":"Tucker B, Goonetilleke N, Patel S et al (2024) Colchicine in atherosclerotic cardiovascular disease. Heart Br Card Soc 110:618\u2013625. https:\/\/doi.org\/10.1136\/heartjnl-2023-323177","journal-title":"Heart Br Card Soc"},{"key":"4399_CR35","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1111\/dom.13702","volume":"21","author":"AP Demidowich","year":"2019","unstructured":"Demidowich AP, Levine JA, Onyekaba GI et al (2019) Effects of colchicine in adults with metabolic syndrome: a pilot randomized controlled trial. Diabetes Obes Metab 21:1642\u20131651. https:\/\/doi.org\/10.1111\/dom.13702","journal-title":"Diabetes Obes Metab"},{"key":"4399_CR36","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/1756-185X.14327","volume":"25","author":"K Jatuworapruk","year":"2022","unstructured":"Jatuworapruk K, Dalbeth N (2022) Are we asking the right questions about urate-lowering therapy? Comment on the 2021 Asia-Pacific League of Associations for Rheumatology clinical practice guideline for treatment of gout. Int J Rheum Dis 25:714\u2013715. https:\/\/doi.org\/10.1111\/1756-185X.14327","journal-title":"Int J Rheum Dis"},{"key":"4399_CR37","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/1756-185X.13266","volume":"21","author":"K-H Yu","year":"2018","unstructured":"Yu K-H, Chen D-Y, Chen J-H et al (2018) Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan. Int J Rheum Dis 21:772\u2013787. https:\/\/doi.org\/10.1111\/1756-185X.13266","journal-title":"Int J Rheum Dis"},{"key":"4399_CR38","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tox.2014.08.002","volume":"324","author":"A Felser","year":"2014","unstructured":"Felser A, Lindinger PW, Schnell D et al (2014) Hepatocellular toxicity of benzbromarone: effects on mitochondrial function and structure. Toxicology 324:136\u2013146. https:\/\/doi.org\/10.1016\/j.tox.2014.08.002","journal-title":"Toxicology"},{"key":"4399_CR39","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1136\/ard.2006.055269","volume":"65","author":"W Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Bardin T et al (2006) EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis 65:1312\u20131324. https:\/\/doi.org\/10.1136\/ard.2006.055269","journal-title":"Ann Rheum Dis"},{"key":"4399_CR40","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200831080-00002","author":"M-HH Lee","year":"2008","unstructured":"Lee M-HH, Graham GG, Williams KM et al (2008) A benefit-risk assessment of benzbromarone in the treatment of gout Was its withdrawal from the market in the best interest of patients? Drug Saf. https:\/\/doi.org\/10.2165\/00002018-200831080-00002","journal-title":"Drug Saf"},{"key":"4399_CR41","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13075-019-1976-x","volume":"21","author":"N Liang","year":"2019","unstructured":"Liang N, Sun M, Sun R et al (2019) Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort. Arthritis Res Ther 21:200. https:\/\/doi.org\/10.1186\/s13075-019-1976-x","journal-title":"Arthritis Res Ther"},{"key":"4399_CR42","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3904\/kjim.2020.410","volume":"35","author":"JH Park","year":"2020","unstructured":"Park JH, Jo Y-I, Lee J-H (2020) Renal effects of uric acid: hyperuricemia and hypouricemia. Korean J Intern Med 35:1291\u20131304. https:\/\/doi.org\/10.3904\/kjim.2020.410","journal-title":"Korean J Intern Med"},{"key":"4399_CR43","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1097\/RHU.0b013e31821d351d","volume":"17","author":"N Kamatani","year":"2011","unstructured":"Kamatani N, Fujimori S, Hada T et al (2011) Placebo-controlled double-blind dose-response study of the non-purine-selective xanthine oxidase inhibitor febuxostat (TMX-67) in patients with hyperuricemia (including gout patients) in japan: late phase 2 clinical study. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis 17:S35-43. https:\/\/doi.org\/10.1097\/RHU.0b013e31821d351d","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"4399_CR44","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2147\/OARRR.S282631","volume":"13","author":"M Talaat","year":"2021","unstructured":"Talaat M, Park K, Schlesinger N (2021) Contentious issues in gout management: the story so far. Open Access Rheumatol Res Rev 13:111\u2013122. https:\/\/doi.org\/10.2147\/OARRR.S282631","journal-title":"Open Access Rheumatol Res Rev"},{"key":"4399_CR45","doi-asserted-by":"publisher","first-page":"159","DOI":"10.5414\/CP204097","volume":"60","author":"YH Lee","year":"2022","unstructured":"Lee YH, Song GG (2022) Comparative efficacy and safety of dotinurad, febuxostat, and benzbromarone in hyperuricemic patients with or without gout: a network meta-analysis of randomized controlled trials. Int J Clin Pharmacol Ther 60:159\u2013166. https:\/\/doi.org\/10.5414\/CP204097","journal-title":"Int J Clin Pharmacol Ther"},{"key":"4399_CR46","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1093\/rheumatology\/keaa668","volume":"60","author":"X Xue","year":"2021","unstructured":"Xue X, Liu Z, Li X et al (2021) The efficacy and safety of citrate mixture vs sodium bicarbonate on urine alkalization in Chinese primary gout patients with benzbromarone: a prospective, randomized controlled study. Rheumatol Oxf Engl 60:2661\u20132671. https:\/\/doi.org\/10.1093\/rheumatology\/keaa668","journal-title":"Rheumatol Oxf Engl"},{"key":"4399_CR47","doi-asserted-by":"publisher","first-page":"1709415","DOI":"10.1155\/2020\/1709415","volume":"2020","author":"J Li","year":"2020","unstructured":"Li J, Zhu W, Gao X et al (2020) Comparison of arthroscopic partial meniscectomy to physical therapy following degenerative meniscus tears: a systematic review and meta-analysis. BioMed Res Int 2020:1709415. https:\/\/doi.org\/10.1155\/2020\/1709415","journal-title":"BioMed Res Int"},{"key":"4399_CR48","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.csm.2022.08.004","volume":"42","author":"MR Mancini","year":"2023","unstructured":"Mancini MR, Horinek JL, Phillips CJ et al (2023) Arthroscopic Rotator cuff repair: a review of surgical techniques and outcomes. Clin Sports Med 42:81\u201394. https:\/\/doi.org\/10.1016\/j.csm.2022.08.004","journal-title":"Clin Sports Med"},{"key":"4399_CR49","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.2147\/JIR.S329800","volume":"14","author":"Z Gong","year":"2021","unstructured":"Gong Z, Xia L, Xu R et al (2021) The clinical effects of febuxostat alone or combined with arthroscopic surgery for gout: a single-center retrospective study. J Inflamm Res 14:4509\u20134517. https:\/\/doi.org\/10.2147\/JIR.S329800","journal-title":"J Inflamm Res"},{"key":"4399_CR50","first-page":"5","volume":"17","author":"How to prevent gout attacks","year":"2013","unstructured":"How to prevent gout attacks (2013) To reduce painful recurrences of gouty arthritis, know your uric acid level and take appropriate doses of medication. Harv Mens Health Watch 17:5","journal-title":"Harv Mens Health Watch"}],"container-title":["European Journal of Orthopaedic Surgery & Traumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00590-025-04399-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00590-025-04399-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00590-025-04399-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T13:41:48Z","timestamp":1767015708000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00590-025-04399-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4399"],"URL":"https:\/\/doi.org\/10.1007\/s00590-025-04399-x","relation":{},"ISSN":["1432-1068"],"issn-type":[{"type":"electronic","value":"1432-1068"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"26 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The Ethics Committee of xxx Rheumatism Hospital has reviewed and approved the ethical approval number CDFS-ETH-2024-05, and the approval date is January 6, 2025.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The study does not have direct contact with the subjects, collects patient data in the case system, the results are only used for analyzing and exploring, and do not serve as any auxiliary diagnostic basis for any commercial use, and the results of the study will be removed from any characters with the subject\u2019s identification, to ensure that personal privacy is not disclosed, so objectively there will be no risk to the subject, and the Ethics Committee has agreed and approved to waive the signing of the informed consent by the subjects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}}],"article-number":"268"}}